JAC Advance Access originally published online on January 16, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2004) 53, 406-407
© 2004 The British Society for Antimicrobial Chemotherapy
Correspondence |
Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VISA) and heteroVISA
Bristol Centre for Antimicrobial Research and Evaluation, Department of Microbiology, North Bristol Health Trust and University of Bristol, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK
Keywords: vancomycin-intermediate Staphylococcus aureus, proteome comparison, sequence analysis
| The first 10% of the full text of this article appears below. |
Sir,
A proteome comparison of the vancomycin-intermediate Staphylococcus aureus (VISA), Mu50 and the vancomycin-susceptible S. aureus (VSSA), N315, concluded that 17 ORFs: murA, metB, yibM, atl, opuD, lysP, mutS, uhpT, modA, glpT, odhA, sdhB, rnr, prfC, mrp-homologue, SA2486 and ribH, appeared to be disrupted in the published Mu50 genome (NC 002758) and
Nucleotide sequence accession numbers
Acknowledgements
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Grundling, D. M. Missiakas, and O. Schneewind Staphylococcus aureus Mutants with Increased Lysostaphin Resistance. J. Bacteriol., September 1, 2006; 188(17): 6286 - 6297. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wootton, P. M. Bennett, A. P. MacGowan, and T. R. Walsh Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains J. Antimicrob. Chemother., November 1, 2005; 56(5): 944 - 947. [Abstract] [Full Text] [PDF] |
||||

